← Back to Search

Cannabinoids

Rest Study Product Usage for Sleep Disorder

N/A
Waitlist Available
Led By Emily K. Pauli, PharmD
Research Sponsored by Radicle Science
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial is testing whether taking plant-derived cannabinoids can help improve sleep and overall health outcomes. The trial is randomized, meaning participants are assigned by chance to either the group taking cannabinoids or the group taking a placebo (a "dummy" pill with no active ingredients). The trial is blinded, meaning that neither the participants nor the researchers know who is taking which pill. The trial is placebo-controlled, meaning that the effects of the cannabinoids are compared to the effects of taking a placebo. Finally, the trial is direct-to-consumer, meaning that it is being advertised to and enrolling participants directly, without going through a doctor.

Eligible Conditions
  • Sleep Disorder
  • Sleep
  • Sleep Disorders

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in sleep disturbance
Secondary outcome measures
Change in anxiety
Change in fatigue
Change in overall quality of life (QOL)
+4 more

Trial Design

13Treatment groups
Experimental Treatment
Placebo Group
Group I: Active Product 4Experimental Treatment1 Intervention
Rest Product Form 4 - active product 1
Group II: Active Product 3.2Experimental Treatment1 Intervention
Rest Product Form 3 - active product 2
Group III: Active Product 3.1Experimental Treatment1 Intervention
Rest Product Form 3 - active product 1
Group IV: Active Product 2.2Experimental Treatment1 Intervention
Rest Product Form 2 - active product 2
Group V: Active Product 2.1Experimental Treatment1 Intervention
Rest Product Form 2 - active product 1
Group VI: Active Product 1.4Experimental Treatment1 Intervention
Rest Product Form 1 - active product 4
Group VII: Active Product 1.3Experimental Treatment1 Intervention
Rest Product Form 1 - active product 3
Group VIII: Active Product 1.2Experimental Treatment1 Intervention
Rest Product Form 1 - active product 2
Group IX: Active Product 1.1Experimental Treatment1 Intervention
Rest Product Form 1 - active product 1
Group X: Placebo Control 1Placebo Group1 Intervention
Rest Product Form 1 - control
Group XI: Placebo Control 2Placebo Group1 Intervention
Rest Product Form 2 - control
Group XII: Placebo Control 3Placebo Group1 Intervention
Rest Product Form 3 - control
Group XIII: Placebo Control 4Placebo Group1 Intervention
Rest Product Form 4 - control
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Rest Study Product Usage
2022
N/A
~2680

Find a Location

Who is running the clinical trial?

Radicle ScienceLead Sponsor
19 Previous Clinical Trials
35,414 Total Patients Enrolled
Emily K. Pauli, PharmDPrincipal InvestigatorRadicle Science, Inc
15 Previous Clinical Trials
27,887 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the intent of this trial?

"According to Radicle Science, the main objective of this 4-week trial is analysing changes in sleep quality. Additionally, investigators will be looking for alterations in overall Quality of Life (QOL) using Kemp's QOL scale (1-7), ascertaining a Minimal Clinically Important Difference (MCID) with regards to Sleep Disturbance as assessed by PROMIS Short form 8A(8-40); and gauging changes in pain intensity via PEG score measurements (0-10)."

Answered by AI

Who meets the criteria for participation in this investigation?

"In order to qualify for this research trial, applicants must be between 21 and 105 years old, demonstrate a good level of health and fitness, and the study is seeking out 300 participants."

Answered by AI

Are there still opportunities to enroll in this research initiative?

"Clinicaltrials.gov confirms that this medical trial, initially posted on September 12th 2022 and edited lastly on October 27th 2022 is no longer recruiting patients at this time. Nevertheless, there are 308 other studies actively looking for enrollees."

Answered by AI

Does this research project include individuals below the age of fifty-five?

"This medical trial requires participants to be between 21 and 105 years of age, per the prerequisites outlined in its inclusion criteria."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Radicle Rest: A Study of Cannabinoids on Sleep and Health Outcomes
2022. "Radicle Rest: A Study of Cannabinoids on Sleep and Health Outcomes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05511818.
~1037 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top